Susan Weisman

Apr 27, 2017

Medite Cancer Diagnostics has appointed Susan Weisman its CFO. She has extensive experience as a financial executive and has worked at Mitsui & Co., BankAtlantic Bancorp, and other companies, Medite said. Weisman has worked with Medite as a consultant since March 2016. 

More Like This

Feb 22, 2019

Jenne Britell, Jeffrey Leiden

Jenne Britell and Jeffrey Leiden have told Quest Diagnostics that they will not seek reelection to the company's board at its annual shareholders' meeting to be held on May 14, Quest said in a document filed with the US Securities and Exchange Commission. They informed the company on Feb. 18. Quest previously announced that Denise Morrison had been elected to the board, increasing its size to 11 directors from 10. 

Feb 21, 2019

Ciarán Kelly, Mark Wilcox, Dale Gerding

First Light Diagnostics has named Ciarán Kelly, Mark Wilcox, and Dale Gerding to its clinical advisory board. Kelly currently serves as the chief of Herman Blumgart Internal Medicine, director of gastroenterology training, and medical director of the Celiac Center at Beth Israel Deaconess Medical Center. Wilcox currently serves as the director of pathology at the Leeds Teaching Hospitals. Gerding previously served as president and chair of the Society for Healthcare Epidemiology of America.

Feb 19, 2019

Anthony Schmidt

Circulogene has named Anthony Schmidt as the firm's medical director. He will lead the lab's precision medicine initiatives and educate the medical community about the firm's technologies. Schmidt was most recently pathology chair and lab medical director for the Mississippi Baptist Healthcare System.

Feb 19, 2019

Leo Grady

Paige.AI has named Leo Grady as its CEO and a board member. The New York-based startup was launched last year and leverages technology developed by its Cofounder and CSO Thomas Fuchs to digitize pathology slides from Memorial Sloan Kettering Cancer Center. The company has a licensing agreement with MSK and said it is on its way to digitizing 5 million pathology slides from the center. Grady was previously senior vice president of engineering for HeartFlow. Prior to that, he was at Siemens where he served in a variety of scientific and leadership positions. 

Feb 19, 2019

Gabrielle Wolfson, Denise Morrison

Gabrielle Wolfson has been appointed Quest Diagnostics' senior vice president and chief information and digital officer. She joins the company fron Xerox where she had been CIO since 2016. Before that, she was CIO at Wyndham Hotels and Resorts and was CIO at Integra Life Sciences and Par Pharmaceutical. 

Quest also announced Denise Morrison has been elected to its board, effective Feb. 18. Morrison was president and CEO of Campbell Soup Company from 2011 to 2018. 

Feb 12, 2019

Sharon Klugewicz

Chembio said in a filing with the US Securities and Exchange Commission that Sharon Klugewicz is resigning as its senior vice president and chief quality and regulatory officer on Feb. 22.

Feb 06, 2019

Peter Kaspar

First Light Diagnostics has appointed Peter Kaspar to its board of directors. Kaspar has been a member of bioMérieux's executive committee, where he was responsible for the firm's molecular diagnostics unit, global research and development, and later the microbiology unit. Kaspar previously held executive roles within several global organizations, including the Foundation for Innovative Diagnostics.

Feb 06, 2019

Patti Connolly, Paul Brenner

RenalytixAI has appointed Patti Connolly as its VP of clinical and scientific affairs. Connolly will lead the firm's recruitment efforts for the prospective clinical utility study for its KidneyIntelX assay, which the firm plans to begin in Q4 2019. Prior to RenalytixAI, Connolly served as clinical services director at Pearl Pathways.

RenalytixAI has also appointed and Paul Brenner to the firm's advisory board. Brenner currently serves as a computer science faculty member at the University of Notre Dame and associate director of Notre Dame's Center for Research Computing. Brenner also serves as a senior reserve advisor to the Air Force Cyber College Commandment.

Jan 29, 2019

Esther Abels

PathAI announced Esther Abels has been appointed its vice president of regulatory and clinical affairs and strategic business development. She will direct the company's development of medical devices and lead its regulatory strategy. Abels was most recently a senior direcgtor at Philips where she led efforts to gain US Food and Drug Administration approval for whole-slide imaging systems. 

Jan 29, 2019

Jean-Francois Yale

Diagnos has appointed Jean-Francois Yale to its board. Yale is an endocrinologist and is currently a professor of medicine at McGill University's department of medicine. He chaired the clinical and scientific section of the Canadian Diabetes Association from 1992-1994.

Jan 28, 2019

Robert Yates, Martin Madaus

Ortho Clinical Diagnostics announced that its board of directors has appointed Robert Yates as chairman and chief executive officer effective Feb. 12. Yates will succeed Martin Madaus, who is retiring after serving as chairman and CEO of Ortho since June 2014. 

Yates is currently Ortho's president and has served as a director on the company's board since June 2014. He was previously the chief operating officer and a member of Ortho's executive leadership team for more than four years.

Jan 25, 2019

John Steuart, Gail Marcus

John Steuart has resigned from Natera's board of directors. The board has also appointed Gail Marcus as chair of the audit committee. She joined Natera's board in March 2017 and currently serves as chair of the nominating and corporate governance committee.

Jan 24, 2019

Greg Thompson

GeneCapture has appointed Greg Thompson as its chief operating officer. Thompson will oversee the product design, commercialization, and medical device approvals for the firm's portable and rapid diagnostic for the point-of-care market. Thompson previously served as VP of design in the medical division and VP of global product design and development at Sanmina. Thompson earned a BSEE degree in computer engineering from North Dakota State University.

Jan 23, 2019

Thomas Montine, Jon Morrow

OptraScan announced the expansion of its medical advisory board with two appointments — Thomas Montine, chairman of the department of pathology at Stanford University School of Medicine, and Jon Morrow, chairman of the department of pathology at Yale School of Medicine.

The firm's medical advisory board already includes Jiaoti Huang, professor and chairman of the department of pathology at Duke University; Allen Gown, founder and medical director at Phenopath; and Abul Abbas, chairman of the department of pathology at University of California, San Francisco.

Jan 22, 2019

Michael Rasche

Metabolon has appointed Michael Rasche as its president of international business. Rasche will lead the firm's international business activities with a focus on customer and team expansion. Prior to Metabolon, Rasche acted as chief commercial officer at Definiens. Before Definiens, Rasche served as corporate VP of global commercial operations at Ayoxxa. He has also held leadership positions at Dako (now Agilent), Roche, and Bayer Diagnostics in Europe, as well as North and South America.